Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia

β-thalassemia is characterised by the presence of an excess of α-globin chains, which contribute to erythrocyte pathology. Here the authors use CRISP/Cas9 to reduce α-globin expression in hematopoietic precursors, and show effectiveness in xenograft assays in mice.

Guardado en:
Detalles Bibliográficos
Autores principales: Sachith Mettananda, Chris A. Fisher, Deborah Hay, Mohsin Badat, Lynn Quek, Kevin Clark, Philip Hublitz, Damien Downes, Jon Kerry, Matthew Gosden, Jelena Telenius, Jackie A. Sloane-Stanley, Paula Faustino, Andreia Coelho, Jessica Doondeea, Batchimeg Usukhbayar, Paul Sopp, Jacqueline A. Sharpe, Jim R. Hughes, Paresh Vyas, Richard J. Gibbons, Douglas R. Higgs
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/0cd23b9b09ec4af18f7d483a67ceba18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0cd23b9b09ec4af18f7d483a67ceba18
record_format dspace
spelling oai:doaj.org-article:0cd23b9b09ec4af18f7d483a67ceba182021-12-02T15:38:49ZEditing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia10.1038/s41467-017-00479-72041-1723https://doaj.org/article/0cd23b9b09ec4af18f7d483a67ceba182017-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00479-7https://doaj.org/toc/2041-1723β-thalassemia is characterised by the presence of an excess of α-globin chains, which contribute to erythrocyte pathology. Here the authors use CRISP/Cas9 to reduce α-globin expression in hematopoietic precursors, and show effectiveness in xenograft assays in mice.Sachith MettanandaChris A. FisherDeborah HayMohsin BadatLynn QuekKevin ClarkPhilip HublitzDamien DownesJon KerryMatthew GosdenJelena TeleniusJackie A. Sloane-StanleyPaula FaustinoAndreia CoelhoJessica DoondeeaBatchimeg UsukhbayarPaul SoppJacqueline A. SharpeJim R. HughesParesh VyasRichard J. GibbonsDouglas R. HiggsNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Sachith Mettananda
Chris A. Fisher
Deborah Hay
Mohsin Badat
Lynn Quek
Kevin Clark
Philip Hublitz
Damien Downes
Jon Kerry
Matthew Gosden
Jelena Telenius
Jackie A. Sloane-Stanley
Paula Faustino
Andreia Coelho
Jessica Doondeea
Batchimeg Usukhbayar
Paul Sopp
Jacqueline A. Sharpe
Jim R. Hughes
Paresh Vyas
Richard J. Gibbons
Douglas R. Higgs
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
description β-thalassemia is characterised by the presence of an excess of α-globin chains, which contribute to erythrocyte pathology. Here the authors use CRISP/Cas9 to reduce α-globin expression in hematopoietic precursors, and show effectiveness in xenograft assays in mice.
format article
author Sachith Mettananda
Chris A. Fisher
Deborah Hay
Mohsin Badat
Lynn Quek
Kevin Clark
Philip Hublitz
Damien Downes
Jon Kerry
Matthew Gosden
Jelena Telenius
Jackie A. Sloane-Stanley
Paula Faustino
Andreia Coelho
Jessica Doondeea
Batchimeg Usukhbayar
Paul Sopp
Jacqueline A. Sharpe
Jim R. Hughes
Paresh Vyas
Richard J. Gibbons
Douglas R. Higgs
author_facet Sachith Mettananda
Chris A. Fisher
Deborah Hay
Mohsin Badat
Lynn Quek
Kevin Clark
Philip Hublitz
Damien Downes
Jon Kerry
Matthew Gosden
Jelena Telenius
Jackie A. Sloane-Stanley
Paula Faustino
Andreia Coelho
Jessica Doondeea
Batchimeg Usukhbayar
Paul Sopp
Jacqueline A. Sharpe
Jim R. Hughes
Paresh Vyas
Richard J. Gibbons
Douglas R. Higgs
author_sort Sachith Mettananda
title Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
title_short Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
title_full Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
title_fullStr Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
title_full_unstemmed Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
title_sort editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/0cd23b9b09ec4af18f7d483a67ceba18
work_keys_str_mv AT sachithmettananda editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT chrisafisher editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT deborahhay editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT mohsinbadat editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT lynnquek editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT kevinclark editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT philiphublitz editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT damiendownes editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jonkerry editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT matthewgosden editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jelenatelenius editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jackieasloanestanley editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT paulafaustino editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT andreiacoelho editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jessicadoondeea editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT batchimegusukhbayar editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT paulsopp editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jacquelineasharpe editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT jimrhughes editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT pareshvyas editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT richardjgibbons editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
AT douglasrhiggs editinganaglobinenhancerinprimaryhumanhematopoieticstemcellsasatreatmentforbthalassemia
_version_ 1718386033055236096